When the autumn booster programme begins next month, many people are likely to receive Moderna’s new
, designed to protect against the original Covid strain and the more transmissible Omicron variant. As Covid continues to evolve, so will vaccination strategies. Here we look at some of the developments in the pipeline.In the past two years we have watched natural selection in action, with successive strains of Covid emerging, each more transmissible and better able to evade previous immunity than the last.
. There are at least 12 nasal vaccines in clinical development, with four in phase 3 trials, and many view an effective nasal vaccine as the next major prize for vaccine research.. The aspirin-sized pill uses an adenovirus, similar to the delivery system used by the Oxford/AstraZeneca vaccine, to deliver instructions for making the Covid spike protein to cells in the gut. This stimulates the release of antibodies in the nose and mouth.
The Walter Reed Army Institute of Research in the US has the only pan-coronavirus vaccine candidate of this type in clinical trials. Other teams are exploring the even more ambitious goal of developing a vaccine that would work for the entire coronavirus family, including the viruses that cause Mers, Sars and seasonal colds.
Amazing how media never tells the truth like how death rate is less than 0.01%. Plus everyone lied and spread misinformation that getting a shot would stop the spread. Safe and approved hey. Truth is not fully approved as studies into safety are not complete.
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: GuardianAus - 🏆 1. / 98 Read more »
Source: abcnews - 🏆 5. / 83 Read more »
Source: abcnews - 🏆 5. / 83 Read more »
Source: abcnews - 🏆 5. / 83 Read more »
Source: abcnews - 🏆 5. / 83 Read more »
Source: FinancialReview - 🏆 2. / 90 Read more »